Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial-Reference-Cited by-同舟云学术

Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial

Published:2024-01-12 Issue: Volume: Page:
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Bagley Stephen J.^ORCID,Binder Zev A.^ORCID,Lamrani Lamia,Marinari Eliana,Desai Arati S.,Nasrallah MacLean P.^ORCID,Maloney Eileen,Brem Steven^ORCID,Lustig Robert A.,Kurtz Goldie,Alonso-Basanta Michelle,Bonté Pierre-Emmanuel^ORCID,Goudot Christel,Richer Wilfrid,Piaggio Eliane,Kothari Shawn,Guyonnet Lea,Guerin Coralie L.^ORCID,Waterfall Joshua J.^ORCID,Mohan Suyash^ORCID,Hwang Wei-Ting^ORCID,Tang Oliver Y.,Logun Meghan,Bhattacharyya Meghna,Markowitz Kelly,Delman Devora,Marshall Amy,Wherry E. John^ORCID,Amigorena Sebastian^ORCID,Beatty Gregory L.,Brogdon Jennifer L.,Hexner Elizabeth,Migliorini Denis^ORCID,Alanio Cecile^ORCID,O’Rourke Donald M.

Funder

Novartis

Agence Nationale de la Recherche

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s43018-023-00709-6.pdf

Reference43 articles.

1. van de Donk, N., Usmani, S. Z. & Yong, K. CAR T-cell therapy for multiple myeloma: state of the art and prospects. Lancet Haematol. 8, e446–e461 (2021).

2. June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64–73 (2018).

3. Bagley, S. J. & O’Rourke, D. M. Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions. Pharmacol. Ther. 205, 107419 (2020).

4. Hou, A. J. et al. Navigating CAR-T cells through the solid-tumour microenvironment.Nat. Rev. Drug Discov. 20, 531–550 (2021).